CagriSema shows promise in Novo Nordisk’s phase 3 obesity trial
Bagsværd, Denmark- December 2024- Novo Nordisk announced headline results from REDEFINE 1,…
Novo Nordisk Gulf receives prestigious Best Places to Work Certification
Kuwait- October 2024- Novo Nordisk Gulf has been recognized as one of…
Novo Nordisk to Present 21 Abstracts at 2024 EASD Annual Meeting
Bagsværd, Denmark- September 2024- Novo Nordisk announced the presentation of 21 abstracts…
Lancet Study: Semaglutide Reduces Risk of CV Death and Worsening Heart Failure
PLAINSBORO, N.J- Recently, The Lancet published a new pooled, participant-level analysis of patients…
Dose Check: Your Personalized Insulin Coach
More than 95% of diabetics suffer from type 2 diabetes, which was…
Is Awiqli® approved for diabetes?
Denmark-21 March 2024- Novo Nordisk announced that the European Medicines Agency’s Committee…